Correlation Between Neola Medical and AlzeCure Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neola Medical and AlzeCure Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neola Medical and AlzeCure Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neola Medical AB and AlzeCure Pharma, you can compare the effects of market volatilities on Neola Medical and AlzeCure Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neola Medical with a short position of AlzeCure Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neola Medical and AlzeCure Pharma.

Diversification Opportunities for Neola Medical and AlzeCure Pharma

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Neola and AlzeCure is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Neola Medical AB and AlzeCure Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzeCure Pharma and Neola Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neola Medical AB are associated (or correlated) with AlzeCure Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzeCure Pharma has no effect on the direction of Neola Medical i.e., Neola Medical and AlzeCure Pharma go up and down completely randomly.

Pair Corralation between Neola Medical and AlzeCure Pharma

Assuming the 90 days trading horizon Neola Medical AB is expected to generate 0.92 times more return on investment than AlzeCure Pharma. However, Neola Medical AB is 1.09 times less risky than AlzeCure Pharma. It trades about 0.21 of its potential returns per unit of risk. AlzeCure Pharma is currently generating about -0.18 per unit of risk. If you would invest  202.00  in Neola Medical AB on September 12, 2024 and sell it today you would earn a total of  54.00  from holding Neola Medical AB or generate 26.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neola Medical AB  vs.  AlzeCure Pharma

 Performance 
       Timeline  
Neola Medical AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neola Medical AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Neola Medical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
AlzeCure Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AlzeCure Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Neola Medical and AlzeCure Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neola Medical and AlzeCure Pharma

The main advantage of trading using opposite Neola Medical and AlzeCure Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neola Medical position performs unexpectedly, AlzeCure Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will offset losses from the drop in AlzeCure Pharma's long position.
The idea behind Neola Medical AB and AlzeCure Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins